Literature DB >> 28316518

Drug-Induced Liver Injury in HIV Patients.

Guy W Neff1, Dushyantha Jayaweera1, Kenneth E Sherman1.   

Abstract

The treatment of HIV has improved over the last decade due in part to the success of treatment with combination-therapy drug "cocktails," better referred to as highly active antiretroviral therapy. The safety and efficacy of these regimens is often complicated by the presence of infectious hepatitis and occurrence of drug-induced liver injury. In most patients, these complications manifest as mild laboratory abnormalities and exist without clinical consequence. However, acute and chronic hepatic injury may lead to increased morbidity and mortality. It is essential to identify all potential causes of liver injury to correctly implement steps to alleviate the condition while maintaining optimal control of HIV viremia.

Entities:  

Keywords:  HAART; HIV; drug-induced liver injury; hepatotoxicity

Year:  2006        PMID: 28316518      PMCID: PMC5350225     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  38 in total

1.  Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population. Royal Free Centre for HIV Medicine.

Authors:  A Mocroft; H Devereux; S Kinloch-de-Loes; D Wilson; S Madge; M Youle; M Tyrer; C Loveday; A N Phillips; M A Johnson
Journal:  AIDS       Date:  2000-07-28       Impact factor: 4.177

Review 2.  Drug-grapefruit juice interactions.

Authors:  G C Kane; J J Lipsky
Journal:  Mayo Clin Proc       Date:  2000-09       Impact factor: 7.616

3.  Acute hepatic failure and lactate acidosis associated with antiretroviral treatment for HIV.

Authors:  Robert O Koch; Ivo W Graziadei; Robert Zangerle; Nikolaus Romani; Hans Maier; Wolfgang Vogel
Journal:  Wien Klin Wochenschr       Date:  2003-02-28       Impact factor: 1.704

4.  Incidence of liver injury after beginning antiretroviral therapy with efavirenz or nevirapine.

Authors:  Luz Martín-Carbonero; Marina Núñez; Juan González-Lahoz; Vincent Soriano
Journal:  HIV Clin Trials       Date:  2003 Mar-Apr

Review 5.  The role of nitric oxide in hepatic metabolism.

Authors:  B Alexander
Journal:  Nutrition       Date:  1998-04       Impact factor: 4.008

6.  A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.

Authors:  A Carr; J Miller; M Law; D A Cooper
Journal:  AIDS       Date:  2000-02-18       Impact factor: 4.177

Review 7.  Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity.

Authors:  T N Kakuda
Journal:  Clin Ther       Date:  2000-06       Impact factor: 3.393

Review 8.  Drugs and steatohepatitis.

Authors:  Geoffrey C Farrell
Journal:  Semin Liver Dis       Date:  2002       Impact factor: 6.115

Review 9.  Herman Award Lecture, 1993: a personal perspective on alcohol, nutrition, and the liver.

Authors:  C S Lieber
Journal:  Am J Clin Nutr       Date:  1993-09       Impact factor: 7.045

10.  Consumption of dietary supplements in a liver transplant population.

Authors:  Guy W Neff; Christopher O'Brien; Marzia Montalbano; Antoinette DeManno; Stephanie Kahn; Kamran Safdar; Seigo Nishida; Andreas Tzakis
Journal:  Liver Transpl       Date:  2004-07       Impact factor: 5.799

View more
  5 in total

1.  A Comparative Analysis of Physiologically Based Pharmacokinetic Models for Human Immunodeficiency Virus and Tuberculosis Infections.

Authors:  Sinenhlanhla Mtshali; Byron A Jacobs
Journal:  Antimicrob Agents Chemother       Date:  2022-07-19       Impact factor: 5.938

Review 2.  Hepatotoxicity of Contemporary Antiretroviral Drugs: A Review and Evaluation of Published Clinical Data.

Authors:  Ashley O Otto; Christina G Rivera; John D Zeuli; Zelalem Temesgen
Journal:  Cells       Date:  2021-05-20       Impact factor: 6.600

3.  Hepatitis B and C infections in HIV-1 patients on combination antiretroviral therapy (cART) in Ghana: implications for immunologic recovery, clinical response to treatment, and hepatotoxicity.

Authors:  Theophilus Benjamin Kwofie; Daniel Adigbli; James Osei-Yeboah; Emmanuel Ativi; Sylvester Yao Lokpo
Journal:  Heliyon       Date:  2021-05-28

4.  Risk Factors for Alanine Aminotransferase Elevations in a Prospective Cohort of HIV-Infected Tanzanian Adults Initiating Antiretroviral Therapy.

Authors:  Sabina F Mugusi; David Sando; Ferdinand M Mugusi; Claudia Hawkins; Said Aboud; Wafaie W Fawzi; Christopher R Sudfeld
Journal:  J Int Assoc Provid AIDS Care       Date:  2019 Jan-Dec

5.  rs1445776009 variants in the human ALB gene: Association with serum albumin and clinical outcomes in HIV-infected Kenyan injection substance users.

Authors:  Erick Barasa; Nathan Shaviya; Valentine Budambula; Tom Were
Journal:  Int J Health Sci (Qassim)       Date:  2021 May-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.